It is very nice to visit Lambda facility and thanks to warm welcome provided by all the teams. I can easily say one of the best CRO I ever visited. People here are wonderful and doing great job

Reputed Client of Israel

Awesome hospitality & fantastic office. All the best!

Reputed Client of Japan

Excellent hospitality and cooperation received throughout the audit. People are knowledgeable and extremely transparent. Looking for long time relation

Reputed Client of Asia

Facility is too good to conduct the BABE studies and adherence to protocol and quality assurance in conducting studies are meeting sponsor expectations and requirements.

Reputed Client of India

Facility is good, people r trained well and know the subject on which they r working. All the best.

Reputed Client of USA

Highly innovative and advanced research centre that possess bright future for the development of the country.

Reputed International Government Body

It is one of the best facility in India for BA/BE

Reputed Regulatory Authority

Lambda is a very professional CRO. All the staff here are experienced and very knowledgeable. I'm grateful for their accommodations and hospitality. The future, if we want to carry out BE study, we will ask Lambda help again.

Reputed Client of Europe

It was a really pleasant meeting with the PV department, and I am looking forward to the next visit.

Reputed Client of Europe

Amazing and best CRO I ever seen

Reputed Client of China


Blog/Regulatory / QA

Home / Blog

EMA Guideline on Computerised Systems and Electronic Data i...

04 Jul 2023

Lambda Therapeutic Research acknowledges the release of the European Medicines Agency - Good Clinical Practice Inspectors Working Group (GCP IWG)'s 'G...

Read More

Key takeaways from the FDA's draft guidance for Decentralize...

04 May 2023

A new Draft Guidance has been released by the FDA, which provides recommendations for sponsors, investigators, and other stakeholders on the implement...

Read More

EMA unveils the new features to enhance the PRIority MEdicin...

18 Apr 2023

To improve its PRIority MEdicines (PRIME) programme, which aims to hasten the development of medicines for unmet needs, the European Medicines Agency ...

Read More

Refuse to Receive Standards

02 Mar 2019

ANDA Submissions- "refuse to receive standards" Draft Guidance Prepared by: Mr. Bhavesh J. Rathod, Mr. Nishant R. Christian & Mr. Manoj K. Patel Ove...

Read More

Looking for a Globally Proven Research Partner?

Contact Us